Join
Live feed
·
PRReleasevia Quantisnow
Lantheus Holdings Inc. logo

Lantheus Acquires Rights to Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (FAP) from Noria

ByQuantisnow·Wall Street's wire, on your screen.
LNTH· Lantheus Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LNTH (Lantheus Holdings Inc.) and more on Quantisnow.